These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 17765442)
1. Metastatic esophageal adenocarcinoma presenting in the iris. Lee WB; Sy HM; Filip DJ; Grossniklaus HE Am J Ophthalmol; 2007 Sep; 144(3):477-9. PubMed ID: 17765442 [TBL] [Abstract][Full Text] [Related]
3. Iris metastasis of esophageal cancer. Ichiki Y; Morita M; Yano K; Sugio K; Yasumoto K; Hirose N Ann Thorac Surg; 2005 May; 79(5):1782-4. PubMed ID: 15854985 [TBL] [Abstract][Full Text] [Related]
4. Metastatic lung adenocarcinoma to the iris mimicking Cogan-Reese syndrome. Harvey BJ; Grossniklaus HE; Traynor MP; Sarkisian SR; Stone DU J Glaucoma; 2012; 21(8):567-9. PubMed ID: 21897284 [TBL] [Abstract][Full Text] [Related]
5. A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer. Evans D; Miner T; Akerman P; Millis R; Jean M; Kennedy T; Safran H Am J Clin Oncol; 2007 Aug; 30(4):346-9. PubMed ID: 17762433 [TBL] [Abstract][Full Text] [Related]
6. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study. Mohammed TA; Dennie T; Holen KD Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751 [No Abstract] [Full Text] [Related]
7. Bilateral acute ptosis leading to the diagnosis of a presumed metastatic gastric adenocarcinoma. Mutyala V; Bains S; Patil C; Madhavarao B Orbit; 2012 Apr; 31(2):134-6. PubMed ID: 22489859 [TBL] [Abstract][Full Text] [Related]
8. A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction. Malik I; Bernal P; Byrd J Cancer Invest; 2010 Oct; 28(8):833-8. PubMed ID: 20839949 [TBL] [Abstract][Full Text] [Related]
9. Red lesions of the iris, choroid, and skin secondary to metastatic carcinoma of the thyroid: a review. Arat YO; Boniuk M Surv Ophthalmol; 2007; 52(5):523-8. PubMed ID: 17719373 [TBL] [Abstract][Full Text] [Related]
10. Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report. Njiaju UO; Truica CI Clin Breast Cancer; 2010 Feb; 10(1):E3-5. PubMed ID: 20133250 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study. Chau I; Ashley S; Cunningham D J Clin Oncol; 2009 Jul; 27(19):e3-4. PubMed ID: 19470917 [No Abstract] [Full Text] [Related]
12. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203 [TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330 [TBL] [Abstract][Full Text] [Related]
14. Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma. Corporaal S; Smit WM; Russel MG; van der Palen J; Boot H; Legdeur MC Neth J Med; 2006 May; 64(5):141-6. PubMed ID: 16702612 [TBL] [Abstract][Full Text] [Related]
16. Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity. Stauffer JA; Mathew J; Odell JA Dis Esophagus; 2011 Jan; 24(1):E8-10. PubMed ID: 21166738 [TBL] [Abstract][Full Text] [Related]
17. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. Al-Batran SE; Hartmann JT; Probst S; Schmalenberg H; Hollerbach S; Hofheinz R; Rethwisch V; Seipelt G; Homann N; Wilhelm G; Schuch G; Stoehlmacher J; Derigs HG; Hegewisch-Becker S; Grossmann J; Pauligk C; Atmaca A; Bokemeyer C; Knuth A; Jäger E; J Clin Oncol; 2008 Mar; 26(9):1435-42. PubMed ID: 18349393 [TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer. Damodaran S; Bellavia T; Sait SN; Wang ES; Wetzler M; Khushalani NI Clin Colorectal Cancer; 2012 Jun; 11(2):151-4. PubMed ID: 22133502 [No Abstract] [Full Text] [Related]
19. Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. Kripp M; Ströbel P; Dinter D; Lukan N; Hochhaus A; Hofheinz RD Anticancer Drugs; 2009 Jan; 20(1):75-8. PubMed ID: 19343004 [TBL] [Abstract][Full Text] [Related]
20. Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer. Andersen M; Schønnemann KR; Yilmaz M; Jensen HA; Vestermark LW; Pfeiffer P Acta Oncol; 2010 Nov; 49(8):1246-52. PubMed ID: 20429725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]